Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
Western Midstream 10M share Spot Secondary priced at $17.35 » 06:12
03/23/21
03/23
06:12
03/23/21
06:12
WES

Western Midstream

$18.27 /

-0.225 (-1.22%)

The deal size was…

The deal size was increased to 10M shares from 8M shares and the range was $17.35-$17.70. BofA acted as sole book running manager for the offering.

ShowHide Related Items >><<
WES Western Midstream
$18.27 /

-0.225 (-1.22%)

WES Western Midstream
$18.27 /

-0.225 (-1.22%)

03/12/21 JPMorgan
Western Midstream upgraded to Overweight from Neutral at JPMorgan
03/05/21 Barclays
Western Midstream price target raised to $22 from $19 at Barclays
02/01/21 Scotiabank
Western Midstream resumed with a Sector Perform at Scotiabank
01/26/21 BofA
Western Midstream upgraded to Neutral from Underperform at BofA
WES Western Midstream
$18.27 /

-0.225 (-1.22%)

  • 23
    Mar
WES Western Midstream
$18.27 /

-0.225 (-1.22%)

On The Fly
Fly Intel: After-Hours Movers » 18:38
03/22/21
03/22
18:38
03/22/21
18:38
BLFS

BioLife Solutions

$38.52 /

-0.33 (-0.85%)

, GHLD

Guild Holdings

$15.23 /

+0.4 (+2.70%)

, KODK

Eastman Kodak

$8.25 /

-0.06 (-0.72%)

, DSP

Viant

$59.34 /

+7.11 (+13.61%)

, RAVN

Raven

$36.06 /

-0.48 (-1.31%)

, IONS

Ionis Pharmaceuticals

$55.63 /

+1.39 (+2.56%)

, XGN

Exagen

$19.83 /

-0.17 (-0.85%)

, QS

QuantumScape

$64.19 /

+4.93 (+8.32%)

, PLL

Piedmont Lithium

$81.70 /

+2.95 (+3.75%)

, MP

MP Materials

$45.20 /

-0.79 (-1.72%)

, WES

Western Midstream

$18.27 /

-0.225 (-1.22%)

, VRCA

Verrica Pharmaceuticals

$16.54 /

+0.445 (+2.77%)

Check out this evening's…

ShowHide Related Items >><<
XGN Exagen
$19.83 /

-0.17 (-0.85%)

WES Western Midstream
$18.27 /

-0.225 (-1.22%)

VRCA Verrica Pharmaceuticals
$16.54 /

+0.445 (+2.77%)

RAVN Raven
$36.06 /

-0.48 (-1.31%)

QS QuantumScape
$64.19 /

+4.93 (+8.32%)

PLL Piedmont Lithium
$81.70 /

+2.95 (+3.75%)

MP MP Materials
$45.20 /

-0.79 (-1.72%)

KODK Eastman Kodak
$8.25 /

-0.06 (-0.72%)

IONS Ionis Pharmaceuticals
$55.63 /

+1.39 (+2.56%)

GHLD Guild Holdings
$15.23 /

+0.4 (+2.70%)

BLFS BioLife Solutions
$38.52 /

-0.33 (-0.85%)

BLFS BioLife Solutions
$38.52 /

-0.33 (-0.85%)

12/28/20 Northland
BioLife Solutions price target raised to $55 from $35 at Northland
11/09/20 KeyBanc
BioLife Solutions initiated with an Overweight at KeyBanc
10/19/20 B. Riley
BioLife Solutions price target raised to $35.50 from $30 at B. Riley Securities
09/23/20 B. Riley
BioLife Solutions price target raised to $30 from $25.50 at B. Riley FBR
GHLD Guild Holdings
$15.23 /

+0.4 (+2.70%)

01/19/21 JPMorgan
Guild Holdings downgraded to Neutral with $18.50 target at JPMorgan
01/19/21 JPMorgan
Guild Holdings downgraded to Neutral from Overweight at JPMorgan
11/16/20
Fly Intel: Top five analyst initiations
11/16/20 Compass Point
Compass Point starts Guild Holdings at Buy with $20 price target
KODK Eastman Kodak
$8.25 /

-0.06 (-0.72%)

DSP Viant
$59.34 /

+7.11 (+13.61%)

03/08/21
Fly Intel: Top five analyst initiations
03/08/21 Raymond James
Viant initiated with a Market Perform at Raymond James
03/08/21 Canaccord
Viant initiated with a Buy, $52 price target at Canaccord
03/08/21 Needham
Viant initiated with a Buy at Needham
RAVN Raven
$36.06 /

-0.48 (-1.31%)

03/19/21 Lake Street
Raven initiated with a Buy at Lake Street
06/19/20
Fly Intel: Top five analyst initiations
06/19/20 Oppenheimer
Raven initiated with an Outperform at Oppenheimer
06/18/20 Oppenheimer
Raven initiated with an Outperform at Oppenheimer
IONS Ionis Pharmaceuticals
$55.63 /

+1.39 (+2.56%)

03/01/21 Barclays
Ionis Pharmaceuticals upgraded to Equal Weight from Underweight at Barclays
02/24/21 Piper Sandler
Ionis Pharmaceuticals price target lowered to $55 from $60 at Piper Sandler
12/28/20 Piper Sandler
Ionis partner data inconclusive in Huntington's disease, says Piper Sandler
12/24/20 Benchmark
Ionis starting to be treated as M&A target, says Benchmark
XGN Exagen
$19.83 /

-0.17 (-0.85%)

03/17/21 Cowen
Exagen price target raised to $26 from $21 at Cowen
12/29/20 Cantor Fitzgerald
Exagen amended Janssen terms removes uncertainty, says Cantor Fitzgerald
11/09/20 KeyBanc
Exagen initiated with an Overweight at KeyBanc
10/07/20 BTIG
Exagen assumed with a Buy at BTIG
QS QuantumScape
$64.19 /

+4.93 (+8.32%)

03/08/21 Cowen
Cowen bullish on battery technology, starts QuantumScape at Outperform
03/08/21 Cowen
QuantumScape initiated with an Outperform at Cowen
03/04/21 Baird
QuantumScape initiated with a Neutral at Baird
02/11/21 Morgan Stanley
QuantumScape initiated with an Overweight at Morgan Stanley
PLL Piedmont Lithium
$81.70 /

+2.95 (+3.75%)

03/04/21 B. Riley
Piedmont Lithium price target raised to $93 from $66 at B. Riley Securities
02/09/21 Evercore ISI
Evercore boosts Piedmont Lithium target to $75, sees path to $90 per share
01/25/21 B. Riley
Piedmont Lithium initiated with a Buy at B. Riley Securities
01/22/21
Fly Intel: Top five analyst initiations
MP MP Materials
$45.20 /

-0.79 (-1.72%)

03/10/21 Cowen
MP Materials initiated with an Outperform at Cowen
03/09/21 Deutsche Bank
MP Materials downgraded to Hold on valuation at Deutsche Bank
03/08/21 Deutsche Bank
MP Materials downgraded to Hold from Buy at Deutsche Bank
03/02/21
Fly Intel: Top five analyst initiations
WES Western Midstream
$18.27 /

-0.225 (-1.22%)

03/12/21 JPMorgan
Western Midstream upgraded to Overweight from Neutral at JPMorgan
03/05/21 Barclays
Western Midstream price target raised to $22 from $19 at Barclays
02/01/21 Scotiabank
Western Midstream resumed with a Sector Perform at Scotiabank
01/26/21 BofA
Western Midstream upgraded to Neutral from Underperform at BofA
VRCA Verrica Pharmaceuticals
$16.54 /

+0.445 (+2.77%)

03/08/21 H.C. Wainwright
Verrica Pharmaceuticals price target raised to $24 from $21 at H.C. Wainwright
12/24/20 Cowen
Verrica approval for molluscum likely in Q3 of 2021, says Cowen
12/24/20 H.C. Wainwright
Verrica Pharmaceuticals price target raised to $21 from $18 at H.C. Wainwright
07/15/20 BofA
Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA
XGN Exagen
$19.83 /

-0.17 (-0.85%)

WES Western Midstream
$18.27 /

-0.225 (-1.22%)

VRCA Verrica Pharmaceuticals
$16.54 /

+0.445 (+2.77%)

RAVN Raven
$36.06 /

-0.48 (-1.31%)

MP MP Materials
$45.20 /

-0.79 (-1.72%)

KODK Eastman Kodak
$8.25 /

-0.06 (-0.72%)

IONS Ionis Pharmaceuticals
$55.63 /

+1.39 (+2.56%)

GHLD Guild Holdings
$15.23 /

+0.4 (+2.70%)

DSP Viant
$59.34 /

+7.11 (+13.61%)

BLFS BioLife Solutions
$38.52 /

-0.33 (-0.85%)

  • 25
    Mar
  • 24
    Mar
  • 23
    Mar
  • 23
    Mar
  • 23
    Mar
  • 24
    Mar
  • 10
    Feb
  • 22
    Oct
  • 22
    Oct
  • 02
    Jul
  • 09
    Jun
QS QuantumScape
$64.19 /

+4.93 (+8.32%)

KODK Eastman Kodak
$8.25 /

-0.06 (-0.72%)

WES Western Midstream
$18.27 /

-0.225 (-1.22%)

RAVN Raven
$36.06 /

-0.48 (-1.31%)

QS QuantumScape
$64.19 /

+4.93 (+8.32%)

PLL Piedmont Lithium
$81.70 /

+2.95 (+3.75%)

MP MP Materials
$45.20 /

-0.79 (-1.72%)

KODK Eastman Kodak
$8.25 /

-0.06 (-0.72%)

IONS Ionis Pharmaceuticals
$55.63 /

+1.39 (+2.56%)

GHLD Guild Holdings
$15.23 /

+0.4 (+2.70%)

DSP Viant
$59.34 /

+7.11 (+13.61%)

BLFS BioLife Solutions
$38.52 /

-0.33 (-0.85%)

QS QuantumScape
$64.19 /

+4.93 (+8.32%)

PLL Piedmont Lithium
$81.70 /

+2.95 (+3.75%)

MP MP Materials
$45.20 /

-0.79 (-1.72%)

KODK Eastman Kodak
$8.25 /

-0.06 (-0.72%)

Syndicate
Western Midstream announces offering of 8M common units for holders » 16:23
03/22/21
03/22
16:23
03/22/21
16:23
WES

Western Midstream

$18.27 /

-0.225 (-1.22%)

Western Midstream…

Western Midstream Partners announced the commencement of an underwritten secondary public offering of 8M common units representing limited partner interests in WES by an affiliate of Occidental Petroleum Corporation. BofA Securities is acting as the sole book-running manager for the offering.

ShowHide Related Items >><<
WES Western Midstream
$18.27 /

-0.225 (-1.22%)

WES Western Midstream
$18.27 /

-0.225 (-1.22%)

03/12/21 JPMorgan
Western Midstream upgraded to Overweight from Neutral at JPMorgan
03/05/21 Barclays
Western Midstream price target raised to $22 from $19 at Barclays
02/01/21 Scotiabank
Western Midstream resumed with a Sector Perform at Scotiabank
01/26/21 BofA
Western Midstream upgraded to Neutral from Underperform at BofA
WES Western Midstream
$18.27 /

-0.225 (-1.22%)

WES Western Midstream
$18.27 /

-0.225 (-1.22%)

Over a month ago
Upgrade
Western Midstream upgraded to Overweight from Neutral at JPMorgan » 07:16
03/12/21
03/12
07:16
03/12/21
07:16
WES

Western Midstream

$19.65 /

-0.47 (-2.34%)

JPMorgan analyst Jeremy…

JPMorgan analyst Jeremy Tonet upgraded Western Midstream Partners to Overweight from Neutral with a $25 price target. The company's "flourishing" free cash flow provides deleveraging and buybacks at a "discounted" valuation, Tonet tells investors in a research note. The analyst sees "more room to run" in the shares.

ShowHide Related Items >><<
WES Western Midstream
$19.65 /

-0.47 (-2.34%)

WES Western Midstream
$19.65 /

-0.47 (-2.34%)

03/05/21 Barclays
Western Midstream price target raised to $22 from $19 at Barclays
02/01/21 Scotiabank
Western Midstream resumed with a Sector Perform at Scotiabank
01/26/21 BofA
Western Midstream upgraded to Neutral from Underperform at BofA
01/20/21 Mizuho
Western Midstream price target raised to $22 from $15 at Mizuho
WES Western Midstream
$19.65 /

-0.47 (-2.34%)

WES Western Midstream
$19.65 /

-0.47 (-2.34%)

Recommendations
Western Midstream price target raised to $22 from $19 at Barclays » 06:55
03/05/21
03/05
06:55
03/05/21
06:55
WES

Western Midstream

$19.79 /

+0.575 (+2.99%)

Barclays analyst…

Barclays analyst Christopher Tillett raised the firm's price target on Western Midstream Partners to $22 from $19 and keeps an Overweight rating on the shares. The company's cash flow profile "leads the pack," having generated north of $500M in excess free cash flow in 2020 despite the challenging macro backdrop by taking decisive actions to prudently manage the business, Tillett tells investors in a research note.

ShowHide Related Items >><<
WES Western Midstream
$19.79 /

+0.575 (+2.99%)

WES Western Midstream
$19.79 /

+0.575 (+2.99%)

02/01/21 Scotiabank
Western Midstream resumed with a Sector Perform at Scotiabank
01/26/21 BofA
Western Midstream upgraded to Neutral from Underperform at BofA
01/20/21 Mizuho
Western Midstream price target raised to $22 from $15 at Mizuho
01/12/21 Barclays
Western Midstream upgraded to Overweight from Equal Weight at Barclays
WES Western Midstream
$19.79 /

+0.575 (+2.99%)

WES Western Midstream
$19.79 /

+0.575 (+2.99%)

Earnings
Western Midstream sees FY21 adjusted EBITDA $1.825B-$1.925B » 16:22
02/23/21
02/23
16:22
02/23/21
16:22
WES

Western Midstream

$16.63 /

+0.71 (+4.46%)

Sees FY21: Total capital…

Sees FY21: Total capital expenditures between $275M-$375M; Debt to Trailing Twelve Month Adjusted EBITDA at or below 4.0 times at year-end 2021; Full-year 2021 distributions of at least $1.24 per unit.

ShowHide Related Items >><<
WES Western Midstream
$16.63 /

+0.71 (+4.46%)

WES Western Midstream
$16.63 /

+0.71 (+4.46%)

02/01/21 Scotiabank
Western Midstream resumed with a Sector Perform at Scotiabank
01/26/21 BofA
Western Midstream upgraded to Neutral from Underperform at BofA
01/20/21 Mizuho
Western Midstream price target raised to $22 from $15 at Mizuho
01/12/21 Barclays
Western Midstream upgraded to Overweight from Equal Weight at Barclays
WES Western Midstream
$16.63 /

+0.71 (+4.46%)

WES Western Midstream
$16.63 /

+0.71 (+4.46%)

Earnings
Western Midstream reports Q4 EPS 62c, consensus 58c » 16:21
02/23/21
02/23
16:21
02/23/21
16:21
WES

Western Midstream

$16.63 /

+0.71 (+4.46%)

Reports Q4 revenue…

Reports Q4 revenue $647.48M, consensus $687.27M.

ShowHide Related Items >><<
WES Western Midstream
$16.63 /

+0.71 (+4.46%)

WES Western Midstream
$16.63 /

+0.71 (+4.46%)

02/01/21 Scotiabank
Western Midstream resumed with a Sector Perform at Scotiabank
01/26/21 BofA
Western Midstream upgraded to Neutral from Underperform at BofA
01/20/21 Mizuho
Western Midstream price target raised to $22 from $15 at Mizuho
01/12/21 Barclays
Western Midstream upgraded to Overweight from Equal Weight at Barclays
WES Western Midstream
$16.63 /

+0.71 (+4.46%)

WES Western Midstream
$16.63 /

+0.71 (+4.46%)

Initiation
Western Midstream resumed with a Sector Perform at Scotiabank » 08:53
02/01/21
02/01
08:53
02/01/21
08:53
WES

Western Midstream

$14.78 /

+0.232 (+1.59%)

Scotiabank analyst Alonso…

Scotiabank analyst Alonso Guerra-Garcia resumed coverage of Western Midstream with a Sector Perform rating and $21 price target. While an improved free cash flow profile has Western "well on its way to de-leveraging and buying back units," he is cautious on single-sponsor risk and "outsized exposure" to the Denver-Julesburg basin, the analyst tells investors.

ShowHide Related Items >><<
WES Western Midstream
$14.78 /

+0.232 (+1.59%)

WES Western Midstream
$14.78 /

+0.232 (+1.59%)

01/26/21 BofA
Western Midstream upgraded to Neutral from Underperform at BofA
01/20/21 Mizuho
Western Midstream price target raised to $22 from $15 at Mizuho
01/12/21 Barclays
Western Midstream upgraded to Overweight from Equal Weight at Barclays
12/17/20 Credit Suisse
Western Midstream upgraded to Outperform from Neutral at Credit Suisse
WES Western Midstream
$14.78 /

+0.232 (+1.59%)

WES Western Midstream
$14.78 /

+0.232 (+1.59%)

Upgrade
Western Midstream upgraded to Neutral from Underperform at BofA » 05:54
01/26/21
01/26
05:54
01/26/21
05:54
WES

Western Midstream

$15.10 /

-0.13 (-0.85%)

BofA upgraded Western…

BofA upgraded Western Midstream to Neutral from Underperform with a $16 price target.

ShowHide Related Items >><<
WES Western Midstream
$15.10 /

-0.13 (-0.85%)

WES Western Midstream
$15.10 /

-0.13 (-0.85%)

01/20/21 Mizuho
Western Midstream price target raised to $22 from $15 at Mizuho
01/12/21 Barclays
Western Midstream upgraded to Overweight from Equal Weight at Barclays
12/17/20 Credit Suisse
Western Midstream upgraded to Outperform from Neutral at Credit Suisse
12/04/20 Barclays
Western Midstream price target raised to $16 from $10 at Barclays
WES Western Midstream
$15.10 /

-0.13 (-0.85%)

WES Western Midstream
$15.10 /

-0.13 (-0.85%)

Recommendations
Western Midstream price target raised to $22 from $15 at Mizuho » 07:17
01/20/21
01/20
07:17
01/20/21
07:17
WES

Western Midstream

$16.52 /

-0.03 (-0.18%)

Mizuho analyst Gabriel…

Mizuho analyst Gabriel Moreen raised the firm's price target on Western Midstream to $22 from $15 and keeps a Buy rating on the shares. 2020 may have "accelerated the maturation of a midstream sector previously accustomed to outspending cash flow and accelerated the forced a reset of its business strategy for the better," Moreen tells investors in a research note. Moving into 2021, the analyst expects heightened emphasis on capital discipline and free cash flow generation "that can continue the drive to remove the sector's leverage overhang once and for all." Beside a "surprisingly supportive" commodity backdrop, further catalysts may come from needed sector consolidation, says Moreen.

ShowHide Related Items >><<
WES Western Midstream
$16.52 /

-0.03 (-0.18%)

WES Western Midstream
$16.52 /

-0.03 (-0.18%)

01/12/21 Barclays
Western Midstream upgraded to Overweight from Equal Weight at Barclays
12/17/20 Credit Suisse
Western Midstream upgraded to Outperform from Neutral at Credit Suisse
12/04/20 Barclays
Western Midstream price target raised to $16 from $10 at Barclays
11/30/20 Wells Fargo
Western Midstream upgraded to Overweight from Underweight at Wells Fargo
WES Western Midstream
$16.52 /

-0.03 (-0.18%)

WES Western Midstream
$16.52 /

-0.03 (-0.18%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.